Osimertinib lung cancer drug molecule

Osimertinib lung cancer drug molecule

C027/5774 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.0MB

Downloadable file size: 529.9KB

Price image Pricing

Please login to use the price calculator


Credit: DR TIM EVANS/SCIENCE PHOTO LIBRARY

Caption: Osimertinib lung cancer drug molecule. Computer model showing the structure of a molecule of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib, which is used to treat advanced non-small-cell lung carcinoma (NSCLC, cancer). Atoms are colour-coded: carbon (light blue), hydrogen (white), oxygen (red), nitrogen (dark blue).

Release details: Model release not required. Property release not required.

Keywords: 1, artwork, ball and stick, ball-and-stick, biochemical, biochemistry, biological, biology, black background, chemotherapy, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, drug, egfr, epidermal growth factor receptor, illustration, lung cancer, medical, medicine, molecular model, molecule, no-one, nobody, non-small-cell lung carcinoma, nsclc, oncological, oncology, one, osimertinib, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pulmonary, single, structure, tki, treatment, tyrosine kinase inhibitor

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.